Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00610480 · ClinicalTrials.gov registry record · NA
Tear Film Stability After Instillation of Over-the-Counter (OTC) Artificial Drops
A NA study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT00610480 is a NA study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT00610480, a NA study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The goal of this research is to evaluate and compare the effectiveness of Systane® versus Optive™ on aqueous tear film stability in patients with a diagnosis of Dry Eye Syndrome and to determine the possible application for this product in the future. Systane® is marketed as over-the-counter tear lubricating therapy in the United States under the FDA monograph.
Interventions
- DRUG 1st visit Optive, then 2nd visit Systane
- DRUG 1st visit Systane, then 2nd visit Optive
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2007-11 |
| Est. Completion | 2009-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00610480
The ClinicalTrials.gov registry entry for NCT00610480 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which 1st visit Optive, then 2nd visit Systane is the first listed.
NCT00610480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00610480 about?
NCT00610480 is a clinical study titled "Tear Film Stability After Instillation of Over-the-Counter (OTC) Artificial Drops". The goal of this research is to evaluate and compare the effectiveness of Systane® versus Optive™ on aqueous tear film stability in patients with a diagnosis of Dry Eye Syndrome and to determine the possible application for this product in the future. Systane® is marketed as over-the-counter tear lu...
What is the current status of trial NCT00610480?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2007-11. Estimated completion is 2009-03.
What interventions are being tested in trial NCT00610480?
The interventions under investigation include: 1st visit Optive, then 2nd visit Systane (DRUG), 1st visit Systane, then 2nd visit Optive (DRUG).
Who is sponsoring clinical trial NCT00610480?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.